THE MULTICOMPONENT COMPLEX NEFRADOZ IN THE TREATMENT OF PATIENTS WITH UROLITHIASIS
Issue:
8
Year:
2015
The efficacy and safety of the multicomponent complex Nefradoz that was used to treat patients with nephrolithiasis after extracorporeal shock-wave lithotripsy and as a drug of lithokinetic therapy in patients with a stone in the lower third of the ureter were investigated. The treatment of 75 patients with nephrolithiasis was analyzed. Incorporation of nefradoz into a complex of treatment for patients with nephrolithiasis enhances the efficiency of lithokinetic therapy and favors the more favorable course in the postoperative period after extracorporeal shock-wave lithotripsy.
Keywords:
urolithiasis
Nefradoz
extracorporeal shock-wave lithotripsy
contact lithotripsy
References:
- Polienko A.K., Sevost'janova O.A., Moiseev V.A. Vlijanie nekotoryh prichin na rasprostranenie mochekamennoj bolezni v mire // Urologija. – 2006; 1: 74–8.
- Aljaev Ju.G., Amosov A.V., Saenko V.S. Metafilaktika mochekamennoj bolezni / M., 2007; 350 s.
- Dzeranov N.K. Sovremennyj podhod k diagnostike i lecheniju mocheka mennoj bolezni u detej // Lechaschij vrach. – 2006; 10: 62–5.
- Lopatkin N.A., Jakovenko E.K. Mochekamennaja bolezn' // Rus. med. 4. zhurn. – 2000; 8 (3): 117–20.
- Pytel' Ju.A., Zolotarev I.I. Neotlozhnaja urologija / M.: Meditsina, 5. 1985; s. 149–53.